AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 1 filers reported holding AKCEA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $818,000 | +32.4% | 45,100 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $618,000 | +18.6% | 45,100 | +23.9% | 0.00% | 0.0% |
| Q1 2020 | $521,000 | -13.6% | 36,400 | +2.2% | 0.00% | 0.0% |
| Q4 2019 | $603,000 | +12.5% | 35,600 | +2.3% | 0.00% | 0.0% |
| Q3 2019 | $536,000 | -31.4% | 34,800 | +4.5% | 0.00% | 0.0% |
| Q2 2019 | $781,000 | -15.2% | 33,300 | +2.5% | 0.00% | 0.0% |
| Q1 2019 | $921,000 | +0.9% | 32,500 | +7.3% | 0.00% | 0.0% |
| Q4 2018 | $913,000 | -7.9% | 30,300 | +7.1% | 0.00% | 0.0% |
| Q3 2018 | $991,000 | +47.7% | 28,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $671,000 | -7.4% | 28,300 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $725,000 | +47.7% | 28,300 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $491,000 | – | 28,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |